LOTTE Biologics and Ottimo Pharma Forge Stronger Partnership in Antibody Development#South_Korea#Seoul#Ottimo_Pharma#LOTTE_BIOLOGICS#OTP-01
LOTTE Biologics and Ottimo Pharma Forge Stronger Partnership in Antibody Development
LOTTE Biologics has expanded its collaboration with Ottimo Pharma, reinforcing their strategic partnership in developing unique antibodies.
third-news.com
May 18, 2026 at 12:13 AM
LOTTE Biologics and Ottimo Pharma Forge Stronger Partnership in Antibody Development#South_Korea#Seoul#Ottimo_Pharma#LOTTE_BIOLOGICS#OTP-01
LOTTE Biologics and Ottimo Pharma Strengthen Their Strategic Partnership in Antibody Development#South_Korea#Seoul#Ottimo_Pharma#LOTTE_BIOLOGICS#OTP-01
LOTTE Biologics and Ottimo Pharma Strengthen Their Strategic Partnership in Antibody Development
LOTTE Biologics enhances collaboration with Ottimo Pharma to advance innovative PD-1/VEGFR2 antibodies, showcasing a commitment to quality and operational excellence.
third-news.com
May 18, 2026 at 12:13 AM
LOTTE Biologics and Ottimo Pharma Strengthen Their Strategic Partnership in Antibody Development#South_Korea#Seoul#Ottimo_Pharma#LOTTE_BIOLOGICS#OTP-01
LOTTE BIOLOGICS Expands Global Reach with New Contract Manufacturing Deal#South_Korea#Seoul#Ottimo_Pharma#LOTTE_BIOLOGICS#antibody_therapeutics
LOTTE BIOLOGICS Expands Global Reach with New Contract Manufacturing Deal
LOTTE BIOLOGICS has secured a manufacturing deal with Ottimo Pharma to produce antibody therapeutics, marking a significant milestone for the biopharmaceutical company.
third-news.com
June 18, 2025 at 11:19 PM
LOTTE BIOLOGICS Expands Global Reach with New Contract Manufacturing Deal#South_Korea#Seoul#Ottimo_Pharma#LOTTE_BIOLOGICS#antibody_therapeutics
LOTTE BIOLOGICS and Ottimo Pharma Join Forces for Antibody Productivity#South_Korea#Seoul#Ottimo_Pharma#LOTTE_BIOLOGICS#Antibody_Therapies
LOTTE BIOLOGICS and Ottimo Pharma Join Forces for Antibody Productivity
LOTTE BIOLOGICS has established a manufacturing partnership with Ottimo Pharma for innovative antibody therapeutics, marking a key step in cancer treatment advancements.
third-news.com
June 18, 2025 at 11:09 PM
LOTTE BIOLOGICS and Ottimo Pharma Join Forces for Antibody Productivity#South_Korea#Seoul#Ottimo_Pharma#LOTTE_BIOLOGICS#Antibody_Therapies
Ottimo Pharma Appoints Veteran Leaders to Propel Unique Cancer Therapy Forward#London#United_Kingdom#Leadership_Team#Ottimo_Pharma#Jankistomig
Ottimo Pharma Appoints Veteran Leaders to Propel Unique Cancer Therapy Forward
Ottimo Pharma has appointed Robert Tighe and Katherine Bell-McGuinn to enhance its leadership, advancing the innovative cancer therapy Jankistomig.
third-news.com
February 25, 2025 at 1:13 PM
Ottimo Pharma Appoints Veteran Leaders to Propel Unique Cancer Therapy Forward#London#United_Kingdom#Leadership_Team#Ottimo_Pharma#Jankistomig
Ottimo Pharma Secures Over $140 Million in Series A Funding to Revolutionize Cancer Treatment#London#cancer_therapy#United_Kingdom#Ottimo_Pharma#Jankistomig
Ottimo Pharma Secures Over $140 Million in Series A Funding to Revolutionize Cancer Treatment
Ottimo Pharma has raised over $140 million in Series A funding to develop innovative bifunctional cancer treatments, led by prominent investors.
third-news.com
December 19, 2024 at 8:06 AM
Ottimo Pharma Secures Over $140 Million in Series A Funding to Revolutionize Cancer Treatment#London#cancer_therapy#United_Kingdom#Ottimo_Pharma#Jankistomig